Gastric inhibitory peptidestimulus Gastric inhibitory peptide (GIP) is a crucial peptide hormone secreted by enteroendocrine K cells in the upper small intestine, primarily the duodenum and jejunum. This hormone plays a significant role in regulating glucose homeostasis and is released in response to nutrient intake, particularly carbohydrates and fats. GIP is also known as glucose-dependent insulinotropic polypeptide, highlighting its key function in stimulating insulin secretion from pancreatic beta-cells in a glucose-dependent manner.
Gastric inhibitory peptide originates from specialized cells called K cells, which are abundant in the mucosal lining of the duodenum and jejunum. These enteroendocrine cells are sensitive to the presence of nutrients in the intestinal lumen. When food, especially glucose and fatty acids, enters the upper small intestine, it triggers the release of GIP into the bloodstream作者：JJ Meier·2004·被引用次数：207—Because GIP is released fromendocrine cells in the intestinal mucosain response to meal ingestion and acts to inhibit gastric acid secretion in animals as .... The rate of GIP secretion is closely linked to the rate of nutrient absorption. Duodenal acidification can also stimulate its release.
The primary and most well-established role of GIP is its action as an incretin hormone.It is now believed that the function of GIP is to induce insulin secretion, which is stimulated primarily by hyperosmolarity of glucose in the duodenum. Incretins are gut hormones released after a meal that enhance insulin secretion from the pancreas. GIP acts on pancreatic beta-cells, significantly amplifying insulin release in response to elevated blood glucose levelsIt is synthesised byK cells, which are found in the mucosa of the duodenum and the jejunum of the gastrointestinal tract. GIP receptors are seven-transmembrane .... This glucose-dependent action means that GIP's effect on insulin secretion is most pronounced when blood glucose is high, thus helping to prevent postprandial hyperglycemia.
Beyond its role in insulin secretion, GIP has been shown to influence other physiological processesGastric inhibitory polypeptide (GIP) dose-dependently .... Historically, it was identified for its ability to inhibit gastric acid secretion, although this effect appears to be less significant in humans compared to its role in insulin signaling. Research also indicates that GIP can stimulate the secretion of somatostatin-like immunoreactivity from the stomach and may enhance glucagon secretion at basal glucose levels. Emerging evidence suggests GIP may also have roles in lipid metabolism and appetite regulationMechanisms of fat‐induced gastric inhibitory polypeptide ....
GIP is often discussed alongside another key incretin hormone, glucagon-like peptide-1 (GLP-1).It is synthesised byK cells, which are found in the mucosa of the duodenum and the jejunum of the gastrointestinal tract. GIP receptors are seven-transmembrane ... Both hormones are secreted from the gastrointestinal tract in response to nutrient intake and contribute to the "incretin effect," which describes the phenomenon where oral glucose elicits a greater insulin response than intravenous glucose. While both GIP and GLP-1 stimulate insulin secretion, they originate from different cell types and locations: GIP from K cells in the upper intestine and GLP-1 from L cells in the lower intestine and colon.Gastric Inhibitory Polypeptide and Glucagon-Like Peptide-1 in ... Their actions, while both related to glucose control, have distinct characteristics and therapeutic implications.Ripples of Discovery Created a New Wave of Weight-loss ...
The understanding of GIP's physiological functions has led to significant interest in its therapeutic potential, particularly in the management of type 2 diabetes and obesity.Gastric Inhibitory Polypeptide - an overview While GIP's direct effects on insulin secretion are potent, its role in the broader metabolic landscape is complex作者：TB Usdin·1993·被引用次数：678—Gastric inhibitory polypeptide (GIP), or glucose-dependent insulinotropic peptide,is released from endocrine cells in the small intestineafter meals.. Research continues to explore the intricate mechanisms of GIP action, including its receptors in various tissues, and its interactions with other metabolic hormones. The development of GIP receptor agonists and dual GIP/GLP-1 receptor agonists represents a promising area of pharmacological intervention for metabolic diseases.
In conclusion, gastric inhibitory peptide, or glucose-dependent insulinotropic polypeptide, is a vital hormone secreted from the upper small intestine.Gastric Inhibitory Polypeptide and Glucagon-Like Peptide-1 in ... Its primary function as an incretin hormone in stimulating insulin release is critical for maintaining glucose homeostasis after meals.Gastric inhibitory polypeptide, also known as glucose-dependent insulinotropic polypeptide (GIP), is a 42-amino acid hormone that stimulates insulin (INS; ... Ongoing research continues to uncover the multifaceted roles of GIP, paving the way for novel therapeutic strategies.
Join the newsletter to receive news, updates, new products and freebies in your inbox.